SCENESSE® receives US FDA orphan designation for cutaneous porphyrias
10 February 2016 Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY)...
Read MorePresentation to international porphyria patient group
8 February 2016 Clinuvel Pharmaceuticals Ltd (ASX: CUV; XETRA‐DAX: UR9; ADR: CLVLY)...
Read MoreCEO Brief - January 20, 2016
20 January 2016 Having both received and provided services within the healthcare...
Read More